MOLECULAR DETECTION OF SARS-COV-2 BY REAL-TIME RT-PCR AND THE ASSOCIATION OF IMMUNOLOGICAL MARKERS (IL-4 AND IL-6) WITH COVID-19 PATIENT GROUPS
Downloads
Objective: Coronaviruses (CoVs) refer to one of the RNA virus infections that can appear as diseases affecting humans. They're enveloped viruses with massive single-strand positive-sense RNA genomes that can infect humans, animals, birds, bats, mice, and a number of other wild creatures’ respiratory, gastrointestinal, hepatic, and central nervous systems. Method: Viral samples were collected from 90 patients through nasopharyngeal swabs. COVID-19 and non-COVID-19 serum patients’ cytokines were identified by ELISA, while SARS-CoV-2 IL-4 and IL-6 were recognized using the chemiluminescence method. Result: The S gene is generally present in the early stages of infection, with only a few extended periods of contamination, whereas the E gene appears in the later stages of disease—one to several weeks after the onset of infection—while the N gene appears to a lesser extent. With 90% amino acid homology and fewer modifications over time, the N gene is more regulated and stable. The (S and E gene) heterozygote shows a higher rate than the others. Novelty: This study highlights distinct gene expression patterns of SARS-CoV-2 during different stages of infection, revealing that the N gene exhibits greater stability and regulatory consistency, which could be significant for diagnostic and molecular surveillance applications.
L. Guo, L. Ren, S. Yang, M. Xiao, D. Chang, and F. Yang, “Profiling early humoral response to diagnose novel coronavirus disease (COVID-19),” Clin. Infect. Dis., vol. 71, pp. 778–785, 2020.
P. Zhou, X. L. Yang, and Z. L. Shi, “A pneumonia outbreak associated with a new coronavirus of probable bat origin,” Nature, vol. 579, pp. 270–273, 2020.
T. R. F. Smith, A. Patel, and K. E. Broderick, “Immunogenicity of a DNA vaccine candidate for COVID-19,” Nat. Commun., vol. 11, p. 2601, 2020.
World Health Organization, “Coronavirus disease (COVID-19) pandemic,” 2020. [Online]. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Y. Chen, Q. Liu, and D. Guo, “Emerging coronaviruses: Genome structure, replication, and pathogenesis,” J. Med. Virol., vol. 92, no. 4, pp. 418–423, 2020.
A. Grifoni, J. Sidney, Y. Zhang, R. H. Scheuermann, B. Peters, and A. Sette, “A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2,” Cell Host & Microbe, 2020.
P. A. Rota et al., “Characterization of a novel coronavirus associated with severe acute respiratory syndrome,” Science (80-. )., vol. 300, pp. 1394–1399, 2003.
Y. Zhu et al., “Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates,” Virus Genes, vol. 30, pp. 93–102, 2005.
K. V Holmes and L. Enjuanes, “The SARS coronavirus: a postgenomic era,” Science (80-. )., vol. 300, pp. 1377–1378, 2003.
D. T. Leung et al., “Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid,” J. Infect. Dis., vol. 190, pp. 379–386, 2004.
G. Kampf, “COVID-19: stigmatising the unvaccinated is not justified,” Lancet, vol. 398, no. 10314, p. 1871, 2021.
M. A. Al-Graibawi, A. A. Yousif, H. A. Gharban, and J. Zinsstag, “First serodetection and molecular phylogenetic documentation of Coxiella burnetii isolates from female camels in Wasit governorate, Iraq,” Iraqi J. Vet. Sci., vol. 35, no. Supplement III, pp. 47–52, 2021.
J. Dudley, “COVID-19 Transmission Under the Public Health Radar: High Prevalence in Young Adults for COVID-19 Pandemic Wave 1,” Elsevier, 2022.
V. J. Costela-Ruiz, R. Illescas-Montes, J. M. Puerta-Puerta, C. Ruiz, and L. Melguizo-Rodríguez, “SARS-CoV-2 infection: The role of cytokines in COVID-19 disease,” Front. Immunol., 2020.
J. M. Jin et al., “Gender Differences in Patients with COVID-19: Focus on Severity and Mortality,” Front. Public Heal., 2020.
I. A. A. Saleh, “Tumor necrosis factor-alpha (TNF-α) 308 G/A promoter polymorphisms in gastric cancers patients in Iraq,” Plant Arch., vol. 20, no. 2, pp. 8667–8670, 2020.
B. Huang et al., “Sex-based clinical and immunological differences in COVID-19,” BMC Infect. Dis., 2021.
Centers for Disease Control and Prevention, “Vaccination Offers Higher Protection than Previous COVID-19 Infection,” 2021. [Online]. Available: https://www.cdc.gov/media/releases/2021/s1029-vaccination-offers-higher-protection.html
Copyright (c) 2025 Mustafa Raheem Tuamah, Zahra Mohammed Jasim

This work is licensed under a Creative Commons Attribution 4.0 International License.














